• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Latest Analyst Ratings For Pennant Gr

    6/20/24 1:01:16 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email

    Throughout the last three months, 4 analysts have evaluated Pennant Gr (NASDAQ:PNTG), offering a diverse set of opinions from bullish to bearish.

    The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 0 3 1 0 0
    Last 30D 0 1 0 0 0
    1M Ago 0 0 0 0 0
    2M Ago 0 2 1 0 0
    3M Ago 0 0 0 0 0

    Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.75, a high estimate of $26.00, and a low estimate of $23.00. Surpassing the previous average price target of $22.75, the current average has increased by 8.79%.

    price target chart

    Analyzing Analyst Ratings: A Detailed Breakdown

    A clear picture of Pennant Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

    Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
    Scott Fidel Stephens & Co. Maintains Overweight $25.00 $25.00
    David Macdonald Truist Securities Raises Hold $25.00 $22.00
    Ben Hendrix RBC Capital Raises Outperform $26.00 $21.00
    Scott Fidel Stephens & Co. Maintains Overweight $23.00 $23.00

    Key Insights:

    • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Pennant Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.
    • Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Pennant Gr compared to the broader market.
    • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Pennant Gr's stock. This comparison reveals trends in analysts' expectations over time.

    Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Pennant Gr's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

    Stay up to date on Pennant Gr analyst ratings.

    If you are interested in following small-cap stock news and performance you can start by tracking it here.

    All You Need to Know About Pennant Gr

    Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

    Unraveling the Financial Story of Pennant Gr

    Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

    Revenue Growth: Pennant Gr's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 24.08%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

    Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.13%, the company showcases strong profitability and effective cost control.

    Return on Equity (ROE): Pennant Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 3.41%, the company demonstrates effective use of equity capital and strong financial performance.

    Return on Assets (ROA): Pennant Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 0.88%, the company demonstrates effective utilization of assets and strong financial performance.

    Debt Management: Pennant Gr's debt-to-equity ratio stands notably higher than the industry average, reaching 2.34. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

    The Core of Analyst Ratings: What Every Investor Should Know

    Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

    Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

    If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $PNTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/8/2025Outperform
    William Blair
    12/2/2025$34.00Hold → Buy
    Truist
    11/18/2025$31.00Equal Weight → Overweight
    Wells Fargo
    10/24/2025$30.00Buy
    Jefferies
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    More analyst ratings

    $PNTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Pennant Group

    William Blair initiated coverage of Pennant Group with a rating of Outperform

    12/8/25 8:35:42 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Group upgraded by Truist with a new price target

    Truist upgraded Pennant Group from Hold to Buy and set a new price target of $34.00

    12/2/25 8:17:55 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Group upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Pennant Group from Equal Weight to Overweight and set a new price target of $31.00

    11/18/25 8:16:18 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Pennant Group Inc.

    SCHEDULE 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    1/20/26 1:12:49 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    The Pennant Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Pennant Group, Inc. (0001766400) (Filer)

    11/5/25 4:32:20 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by The Pennant Group Inc.

    10-Q - Pennant Group, Inc. (0001766400) (Filer)

    11/5/25 4:15:55 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Snapper Suzanne D. was granted 1,900 shares, increasing direct ownership by 0.85% to 226,564 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    1/21/26 1:46:09 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Director Lamb Scott E was granted 2,400 shares, increasing direct ownership by 5% to 54,135 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    1/21/26 1:46:16 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Director Christensen Christopher R. was granted 1,900 shares, increasing direct ownership by 1% to 142,191 units (SEC Form 4)

    4 - Pennant Group, Inc. (0001766400) (Issuer)

    1/21/26 1:45:57 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pennant Group to Participate in the 2025 Stephens Annual Investment Conference

    EAGLE, Idaho, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Stephens Annual Investment Conference on November 19, 2025. Lynette Walbom, Chief Financial Officer, John Gochnour, Chief Operating Officer, and Andy Rider, President of Pennant's Senior Living segment, will participate in a fireside chat on November 19, 2025 at 2:00 p.m. Central Time. A live webcast of the event will be accessible at the following address: https://event.summitcast.com/view/4xGMMHuH7TkUARrFoGH3S3/9hyABBCdefiVprW9A6wNB6. Ab

    11/6/25 9:22:41 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    The Pennant Group Announces Expansion of Credit Facility

    EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has added a term loan to its credit facility, increasing the facility by $100 million to an aggregate of $350 million. The borrowings are supported by Pennant's existing lending consortium led by Truist Securities. The interest rate and maturity date of the incremental loan match those of the existing facility. "This expansion of our credit facility further strengthens our balance sheet and gives us additional capacity to fund future growth," said Brent Guerisoli, Penn

    11/5/25 4:10:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Reports Third Quarter 2025 Results

    EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.30 for the quarter(1). Third Quarter Highlights Total revenue for the third quarter was $229.0 million, an increase of $48.4 million or 26.8% over the prior year quarter;Net income for the third quarter was $6.1 million, a decrease of $0.1 million or 2.0% over the prior year quarter;Adjusted net income for the third qu

    11/5/25 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Financials

    Live finance-specific insights

    View All

    Pennant Reports Third Quarter 2025 Results

    EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.30 for the quarter(1). Third Quarter Highlights Total revenue for the third quarter was $229.0 million, an increase of $48.4 million or 26.8% over the prior year quarter;Net income for the third quarter was $6.1 million, a decrease of $0.1 million or 2.0% over the prior year quarter;Adjusted net income for the third qu

    11/5/25 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Acquires Senior Living Communities in Idaho and Wisconsin

    EAGLE, Idaho, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces two significant acquisitions that strengthen its presences in key markets. Effective November 1, 2025, Pennant acquired the operations and real property of a 55-bed assisted living community in Lewiston, Idaho. This community, now known as Twin Rivers Senior Living, reinforces Pennant's strategic commitment to expanding high-quality senior care services across the Mountain West. In addition, effective today, November 4th, Pennant completed the acquisition of the real property for

    11/4/25 6:48:33 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Pennant Reports Second Quarter 2025 Results

    EAGLE, Idaho, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.20 for the second quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). Second Quarter Highlights Total revenue for the second quarter was $219.5 million, an increase of $50.8 million or 30.1% over the prior year quarter;Net income for the second quarter was $7.1 million, an increase of $1.4 million or 24.5% over the prior year quarter;Adjusted net income for the se

    8/6/25 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Leadership Updates

    Live Leadership Updates

    View All

    The Pennant Group Appoints Suzanne Snapper as Director

    EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

    5/16/25 12:12:47 PM ET
    $ENSG
    $PNTG
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

    EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company. Mr. Guerisoli has served on Pennant's board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2

    1/2/25 4:23:29 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    The Pennant Group Appoints Lynette Walbom as Chief Financial Officer

    EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou

    5/22/23 4:05:00 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    $PNTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

    SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    11/14/24 1:28:33 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

    SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

    11/7/24 9:30:29 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by The Pennant Group Inc.

    SC 13G - Pennant Group, Inc. (0001766400) (Subject)

    11/7/24 9:12:22 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care